Ucci Alessandro, Perini Paolo, Freyrie Antonio, Schreve Michiel A, Ünlü Çağdaş, Huizing Eline, van den Heuvel Daniel A, Kum Steven, Shishehbor Mehdi H, Ferraresi Roberto
Vascular Surgery, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Department of Vascular Surgery, Northwest Clinics, Alkmaar, the Netherlands.
J Endovasc Ther. 2023 Nov 27:15266028231210220. doi: 10.1177/15266028231210220.
Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries. Foot vein arterialization (FVA) has been proposed as an alternative technique to provide arterial blood to the foot by using the disease-free venous bed.
This systematic review and meta-analysis aimed to determine outcomes of surgical FVA (sFVA) and percutaneous FVA (pFVA) at 6 and 12 months post-procedure.
PubMed, Scopus, Web of Science, and the Cochrane Library databases were searched to identify papers reporting clinical outcomes of sFVA and pFVA published between January 1966 and March 2023.
Databases were searched for eligible studies. A meta-analysis was performed to evaluate the limb salvage rate, overall survival rate, and wound healing rate at 6 and 12 months.
A total of 27 studies were included, with 753 patients and 793 limbs. Of the included studies, 16 analyzed the sFVA technique and 11 the pFVA technique. Of the included patients, 86.3% were Rutherford 5/6 in the sFVA group versus 98.4% in the pFVA group. The pooled limb salvage rate at 6 and 12 months was 78.1% and 74.1% in the sFVA group and 81.7% and 78.6% in the pFVA group, respectively. Wound healing rates were not reported in the sFVA group. In the pFVA group, the pooled wound healing rates were 48.1% and 64.5% at 6 and 12 months, respectively.
This study showed promising results after FVA among a large population of CLTI patients. In high-risk patients, pFVA is a feasible option with favorable limb salvage and wound healing rates.
慢性肢体威胁性缺血(CLTI)以其高截肢率和死亡率而闻名。由于动脉严重病变,传统的血管重建技术在CLTI患者中常常失败。足静脉动脉化(FVA)已被提出作为一种替代技术,通过使用无病变的静脉床为足部提供动脉血。
本系统评价和荟萃分析旨在确定手术FVA(sFVA)和经皮FVA(pFVA)术后6个月和12个月的结局。
检索了PubMed、Scopus、Web of Science和Cochrane图书馆数据库,以识别1966年1月至2023年3月期间发表的报告sFVA和pFVA临床结局的论文。
在数据库中检索符合条件的研究。进行荟萃分析以评估6个月和12个月时的肢体挽救率、总生存率和伤口愈合率。
共纳入27项研究,涉及753例患者和793条肢体。在纳入的研究中,16项分析了sFVA技术,11项分析了pFVA技术。在纳入的患者中,sFVA组86.3%为卢瑟福5/6级,而pFVA组为98.4%。sFVA组6个月和12个月时的合并肢体挽救率分别为78.1%和74.1%,pFVA组分别为81.7%和78.6%。sFVA组未报告伤口愈合率。在pFVA组中,6个月和12个月时的合并伤口愈合率分别为48.1%和64.5%。
本研究显示,在大量CLTI患者中进行FVA后取得了有前景的结果。在高危患者中,pFVA是一种可行的选择,具有良好的肢体挽救率和伤口愈合率。